Stematix Obtains Exclusive License to Regenexx Stem Cell Procedure Treating Musculoskeletal Disorders in Latin America

 
 
Stematix Inc., announced today it has signed an exclusive royalty-bearing license agreement, for the Latin American territory, to use an innovative process that rapidly grows a patients own adult stem cells to treat a variety of musculoskeletal diseases.

http://ow.ly/wuCl
...


Your friends are reading OrthoStreams daily - Are you ?

 

Unlock your access to full rich article, trends, hot startups, market reports and your daily newsletter.

Just $1/day.